Antibody-drug conjugates (ADCs) are a promising avenue for precision cancer treatments.
In this short animated video, learn the basics of how ADCs are engineered and why that makes them such powerful tools to target cancers with precision.
Dive deeper into the topic of ADC development and the bioconjugation process with further resources: